Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 4, 2016
View Archived Issues
Novel benzylpyrazole-based BUB1 kinase inhibitors with antitumor activity
Read More
INCB-059872 demonstrates promising in vitro and in vivo activity in models of AML
Read More
Graybug Vision closes series B financing to further develop AMD drug
Read More
City of Hope licenses gene editing technology to new company Homology Medicines
Read More
PHSA and University of British Columbia patent labeled compounds for cancer diagnosis
Read More
Sage Therapeutics discloses GABA receptor modulators
Read More
Phase II dose of bispecific antibody MCLA-128 defined in first-in-human solid tumor study
Read More
FDA grants fast track status to Axsome Therapeutics' AXS-02
Read More
MYK-461 granted FDA orphan status for symptomatic obstructive hypertrophic cardiomyopathy
Read More
Juno's JCAR-017 receives diffuse large B-cell lymphoma orphan designation
Read More
GlaxoSmithKline quadrivalent influenza vaccine safe, immunogenic in children under 3 years old
Read More
FDA grants priority review to Blincyto sBLA for pediatric Ph-negative B-cell precursor ALL
Read More
BioNovus Innovations and University of Kansas Medical Center's IAMI form partnership
Read More
Ischemix's phase II CARIN trial misses prespecified endpoints
Read More
Bayer describes novel radioimmunoconjugate BAY-1862864 entering phase I development
Read More
Biogen to spin off hemophilia business
Read More
pSivida's Medidur wins orphan medicinal product designation in Europe
Read More
TG Therapeutics begins phase II study of ublituximab in MS
Read More
Triphase Accelerator and Celgene expand marizomib collaboration
Read More
EMA grants accelerated assessment to cerliponase alfa MAA
Read More
Marina Biotech to acquire Turing's phase III intranasal ketamine program
Read More
Santhera Pharmaceuticals preparing NDA, MAA for Raxone in DMD
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe